Dashboard
Manage Tickers

GBTGlobal Blood Therapeutics Inc.


$ 68.49 $ 0.01 (0.01 %)    

Tuesday, 04-Oct-2022 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 68.49
$ 68.47 x 900
$ 68.50 x 500
-- - --
$ 21.65 - $ 73.02
3,279,961
na
na
$ 1.05
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
White House Says It Will Continue To Monit...
11/10/2022 18:35:24

-Reuters

global-blood-therapeuticss-return-on-capital-employed-overview
Global Blood Therapeutics's Return On Capi...
09/15/2022 14:10:29

Benzinga Pro data, Global Blood Therapeutics (NASDAQ:GBT) reported Q2 sales of $71.55 million. Earnings fell to a loss of $82....

global-blood-therapeuticss-return-on-capital-employed-overview
Global Blood Therapeutics's Return On Capi...
09/01/2022 14:13:53

Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $71.55 million during Q2 according to data provided by Benzing...

after-pfizer-now-novo-nordisk-beefs-up-its-sickle-cell-portfolio-with-forma-therapeutics-deal
After Pfizer, Now Novo Nordisk Beefs Up It...
09/01/2022 13:55:42

analysts-see-softened-timelines-for-crispr-therapeutics-sickle-cell-candidate-in-us
Analysts See Softened Timelines For CRISPR...
08/09/2022 19:26:34

8-analysts-have-this-to-say-about-global-blood-therapeutics
8 Analysts Have This to Say About Global B...
08/09/2022 15:13:34

  Within the last quarter, Global Blood Therapeutics (NASDAQ:GBT) has observed the following analyst ratings:

benzingas-top-ratings-upgrades-downgrades-for-august-9-2022
Benzinga's Top Ratings Upgrades, Downgrade...
08/09/2022 14:13:44

 

where-global-blood-therapeutics-stands-with-analysts
Where Global Blood Therapeutics Stands Wit...
08/09/2022 12:16:03

  Within the last quarter, Global Blood Therapeutics (NASDAQ:GBT) has observed the following analyst ratings:

rbc-capital-downgrades-global-blood-therapeutics-to-sector-perform-raises-price-target-to-685
RBC Capital Downgrades Global Blood Therap...
08/09/2022 11:27:57

RBC Capital analyst Gregory Renza downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Sector Perform and ra...

wells-fargo-downgrades-global-blood-therapeutics-to-equal-weight-raises-price-target-to-685
Wells Fargo Downgrades Global Blood Therap...
08/09/2022 11:10:24

Wells Fargo analyst Jim Birchenough downgrades Global Blood Therapeutics (NASDAQ:GBT) from Overweight to Equal-Weight and ra...

svb-leerink-downgrades-global-blood-therapeutics-to-market-perform-announces-685-price-target
SVB Leerink Downgrades Global Blood Therap...
08/09/2022 10:36:18

SVB Leerink analyst Andrew Berens downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Market Perform and an...

cantor-fitzgerald-downgrades-global-blood-therapeutics-to-neutral-lowers-price-target-to-685
Cantor Fitzgerald Downgrades Global Blood ...
08/09/2022 08:59:23

Cantor Fitzgerald downgrades Global Blood Therapeutics (NASDAQ:GBT) from Overweight to Neutral and lowers the price target fr...

cowen--co-downgrades-global-blood-therapeutics-to-market-perform-raises-price-target-to-685
Cowen & Co. Downgrades Global Blood Therap...
08/09/2022 08:56:58

Cowen & Co. analyst Ritu Baral downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Market Perform and r...

global-blood-therapeutics-q2-earnings-insights
Global Blood Therapeutics: Q2 Earnings Ins...
08/09/2022 03:16:39

  Global Blood Therapeutics (NASDAQ:GBT) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's w...

cabot-corporation-narrows-guidance
Cabot Corporation Narrows Guidance
08/08/2022 20:57:48

why-these-pfizer-analysts-like-the-global-blood-therapeutics-deal
Why These Pfizer Analysts Like The Global ...
08/08/2022 18:50:28

Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood diso...

stifel-downgrades-global-blood-therapeutics-to-hold
Stifel Downgrades Global Blood Therapeutic...
08/08/2022 17:38:24

Stifel analyst Benjamin Burnett downgrades Global Blood Therapeutics (NASDAQ:GBT) from Buy to Hold.

wedbush-downgrades-global-blood-therapeutics-to-neutral
Wedbush Downgrades Global Blood Therapeuti...
08/08/2022 17:35:56

Wedbush analyst Andreas Argyrides downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Neutral.

benzingas-top-ratings-upgrades-downgrades-for-august-8-2022
Benzinga's Top Ratings Upgrades, Downgrade...
08/08/2022 14:10:47

 

jefferies-downgrades-global-blood-therapeutics-to-hold-raises-price-target-to-685
Jefferies Downgrades Global Blood Therapeu...
08/08/2022 13:44:50

Jefferies analyst Akash Tewari downgrades Global Blood Therapeutics (NASDAQ:GBT) from Buy to Hold and raises the price targe...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION